Standard Biotools (LAB) Research & Development (2010 - 2026)

Standard Biotools (LAB) has 17 years of Research & Development data on file, last reported at $2.1 million in Q1 2026.

• On a quarterly basis, Research & Development fell 61.08% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $22.7 million, a 15.0% decrease from a year earlier, with the FY2025 full-year figure at $26.0 million, down 9.86% from the prior year.
• Research & Development for Q1 2026 stood at $2.1 million, down from $8.0 million in the prior quarter.
• Over the last five years, Research & Development for LAB reached as high as $16.0 million in Q1 2024 and fell as low as $2.1 million in Q1 2026.
• Historically, Research & Development has averaged $7.6 million across 5 years, with a median of $6.9 million in 2024.
• Across the five-year window, Research & Development slumped 71.14% in 2022 and jumped 148.56% in 2024, its largest moves.
• Year by year, Research & Development stood at $7.4 million in 2022, then fell by 6.95% to $6.9 million in 2023, then grew by 1.9% to $7.0 million in 2024, then climbed by 13.2% to $8.0 million in 2025, then slumped by 73.43% to $2.1 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $2.1 million in Q1 2026, $8.0 million in Q4 2025, and $6.4 million in Q3 2025.